The 10 references in paper I. Snegireva I., K. Zatolochina E., M. Darmostukova A., R. Alyautdin N., B. Romanov K., И. Снегирева И., К. Затолочина Э., М. Дармостукова А., Р. Аляутдин Н., Б. Романов К. (2018) “Современные подходы к взаимозаменяемости вакцин // Modern approaches to vaccines interchangeability” / spz:neicon:vedomostincesmp:y:2016:i:4:p:3-8

1
Federal Law of Russian Federation of 22.12.2014 ¹ 429-FZ, «On Amendments to the Federal Law «On Circulation of Medicines» (in Russian).
(check this in PDF content)
2
Borzova M. Interchangeability of biological medicines: fantasy or reality? Remedium 2014; (9): 6–13 (in Russian).
(check this in PDF content)
3
Mironov AN, ed. Guidance on the examination of medicines. V. 4. Moscow: Poligraf-Plus; 2014 (in Russian).
(check this in PDF content)
4
Chow SC, Liu JP. Design and Analysis of Bioavailability and Bioequivalence Studies. 3rd ed. New York: CRC Press; 2008.
(check this in PDF content)
5
Ozeretskovsky NA, Zatolochina KE, Snegireva II. Proposals for the prevention of adverse events when using immunobiological drugs in the Russian Federation. Bezopasnost i risk farmakoterapii 2015; (2): 25–9 (in Russian).
(check this in PDF content)
6
Borisevich IV, Vorobieva MS, Gayderova LA, Gorbunov MA, Davydov DS, Ignatiev GM et al. Medical immunobiological preparations. Directory. V. 1. Vaccines. Moscow: Gella-print; 2010 (in Russian).
(check this in PDF content)
7
Snegireva II, Zatolochina KE, Darmostukova MA, Khotova TYu, Alyautdin RN, Ozeretskovsky NA. et al. Vaccine Interchangeability. Uspehi sovremennogo estestvoznaniya 2015; (8): 43–7 (in Russian).
(check this in PDF content)
8
Feldman S. Interchangeability of vaccines. Pediatric Infectious Disease Journal 2001; 20(11): 23–9.
(check this in PDF content)
9
Public Health Agency of Canada. Canadian Immunization Guide. PrinciplesofVaccineInterchangeability.Availablefrom: http://www.phac-aspc.gc.ca/publicat/cig-gci/p01-06-eng.php. 84(40): 405–20. 11. CDC. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2011; 60(RR02): 1–60. Available from: http://www.cdc.gov/ mmwr/preview/mmwrhtml/rr6002a1.htm. 12. CDC. A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of Adults. MMWR 2006; 55(RR16): 1–25. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/ rr5516a1.htm. 13. Hamborsky J, Kroger A, Wolf
(check this in PDF content)
10
Hepatitis B Vaccine. Position Paper WHO. Wkly Epidemiol Rec. 2009; 23. Bush LM, Moonsammy GI, Bosciaj A. Evaluation of initiating a hepatitis B vaccination schedule with one vaccine and completing it with another. Vaccine 1991; (9): 807–9.
(check this in PDF content)